Page 39 - 01.pdf

SEO Version

STATEMENTS OF FINANCIAL POSITION
AS AT 31 DECEMBER 2013
Group
Company
Note
2013
2012
2013
2012
$
$
$
$
Non-current assets
Property, plant and equipment
9
7,411,424
4,047,531
263,190
81,571
Investment in subsidiaries
10
2,566,662
911,413
Investment in associates
11
1,791,010
1,576,060
1,460,060
1,955,060
Convertible loan receivables
20
592,125
588,661
Intangible asset
12
57,139
Goodwill
13
2,124,311
11,976,009
6,212,252
4,289,912
2,948,044
Current assets
Inventories
15
267,816
73,339
Trade receivables
16
1,353,785
987,999
2,917,027
1,896,583
Other receivables and deposits
17
1,752,168
435,306
445,443
240,247
Prepayments
261,502
55,978
187,863
20,804
Cash and short term deposits pledged as security
18
300,000
Cash and short term deposits
19
7,176,868
9,179,193
5,695,901
7,734,459
11,112,139
10,731,815
9,246,234
9,892,093
Current liabilities
Trade payables
21
715,456
318,311
187,464
37,280
Other payables and accruals
22
3,898,288
1,154,819
1,615,185
386,142
Deferred income
23
253,162
500
Current tax liabilities
8,859
Loans and borrowings
24
1,242,009
161,375
Obligations under finance leases
25
709,092
300,000
6,826,866
1,935,005
1,802,649
423,422
Net current assets
4,285,273
8,796,810
7,443,585
9,468,671
Non-current liabilities
Loans and borrowings
24
623,992
502,911
Obligations under finance leases
25
1,674,109
950,000
Put options granted to non-controlling interests
26
652,544
Deferred tax liabilities
14
34,895
151,313
2,985,540
1,604,224
Net assets
13,275,742
13,404,838
11,733,497
12,416,715
Equity attributable to owners of the Company
Share capital
27
21,950,527
21,550,530
21,950,527
21,550,530
Treasury shares
28
(2,866)
(2,866)
(2,866)
(2,866)
Other reserves
(630,186)
(36,416)
Accumulated losses
(7,741,692)
(7,795,638)
(10,214,164)
(9,130,949)
13,575,783
13,715,610
11,733,497
12,416,715
Non-controlling interests
(300,041)
(310,772)
Total equity
13,275,742
13,404,838
11,733,497
12,416,715
The accompanying accounting policies and explanatory notes form an integral part of the financial statements.
ASIAMEDIC LIMITED
ANNUAL REPORT 2013
37